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Transgenic miceLung development is controlled by regulatory networks governing mesenchymal–epithelial interactions.
Transcription factors and signaling molecules are known to participate in this process, yet little is known
about the post-transcriptional regulation of these networks. Here we demonstrate that the RNA-binding
protein (RBP) HuR is an essential regulator of mesenchymal responses during lung branching. Its epiblast-
induced deletion blocked the morphogenesis of distal bronchial branches at the initiation of the
pseudoglandular stage. The phenotype originated from defective mesenchymal responses since the
conditional restriction of HuR deletion in epithelial progenitors did not affect distal branching or the
completion of lung maturation. The loss of HuR resulted in the reduction of the key inducer of bud outgrowth
and endodermal branching, FGF10 and one of its putative transcriptional regulators, Tbx4. Furthermore,
exogenous FGF10 could rescue the branching defect of affected lung buds. HuR was found to bind and control
the Fgf10 and Tbx4mRNAs; as a result its deletion abolished their inducible post-transcriptional regulation by
the mesenchymal regulator FGF9. Our data reveals HuR as the ﬁrst RBP identiﬁed to play a dominant role in
lung development and as a key post-transcriptional regulator of networks guiding tissue remodeling during
branching morphogenesis.BSRC “Alexander Fleming”, 34
4955.
yiannis).
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Lungs develop through a series of delicate morphogenetic steps.
The initiating event is the endodermal projection of the primitive
foregut which ﬁrst invades the adjacent mesoderm, and then
elongates to form the primary lung buds. Later, the endodermal
component of these buds undergoes dichotomous subdivisions and
differentiates over a rapidly proliferating mesenchyme to form the
complex bronchial branches of the airways and then the alveoli of the
respiratory tree. Induced mutations in the mouse revealed that this
process is coordinated by reciprocal paracrine and/or autocrine
signals among the developing endoderm and the adjacent mesen-
chyme (Cardoso and Lu, 2006). The secretion of FGF10 from the
mesenchyme is central to these interactions and drives the outgrowth
of the lung bud as well as attracting epithelia distally during
branching. FGF10 binds to the FGfR2 receptor expressed by the
developing endodermal epithelium, setting off a series of complex
cross-talk signals involving FGFs, TGFβ/Bmp, Shh andWnt to form the
mesenchymal scaffold that assists epithelial outgrowth and differen-
tiation (Cardoso and Lu, 2006;Maeda et al., 2007).
The array of reciprocal interactions involved in lung branching
relies on the proper expression of the genes encoding the appropriate
signalingmolecules to drive the process. Recent studies have reportedthe emerging role of microRNAs as regulators of lung branching
morphogenesis (Carraro et al., 2009; Dong et al., n.d.; Harris et al.,
2006), suggesting that post-transcriptional mechanisms could be
involved in the process. Post-transcriptional regulators include RNA-
binding proteins (RBPs) that determine mRNA maturation, localiza-
tion, stability and translation (Keene, 2007).Within the large family of
RBPs, HuR has emerged as a pleiotropic modulator of mRNA
utilization, particularly for mRNAs possessing of U- and AU-rich
elements. HuR contains RNA recognition motifs (RRMs) with afﬁnity
for a U-rich motif and it is the only ubiquitously expressed member of
the otherwise neuronal Elavl/Hu family (Keene, 1999). HuR binds to
its target RNAs and shuttles between the nucleus and the cytoplasm
via interactions with nuclear export/import adaptor proteins and
several signaling modules (Gallouzi and Steitz, 2001). In the
cytoplasm, HuR can affect mRNA stability and/or translation through
complex interplay with ribonucleoprotein structures containing
members of the hnRNP, TTP and TIA families as well as micro-RNAs
(Katsanou et al., 2006; van der Giessen and Gallouzi, 2007).
HuR expression is known to vary throughout extraembryonic and
embryonic development (Gouble and Morello, 2000;Katsanou et al.,
2009). Loss and gain-of function experiments suggested that HuR is
involved in the control of the cell cycle, differentiation programs and
stress responses of numerous cell types (Abdelmohsen et al., 2007;
Gorospe, 2003; Keene, 1999;Levadoux-Martin et al., 2003;van der
Giessen and Gallouzi, 2007). In vivo, deletion of HuR in the mouse
blocks the morphogenesis of the extraembryonic placenta, leading to
embryonic lethality (Katsanou et al., 2009). Tissue-speciﬁc ablation
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patterning and spleen development (Katsanou et al., 2009). A
common denominator in these phenotypes is their dependency on
cross talk between mesenchyme and endodermal epithelium.
However, the role of HuR in this process has not been elucidated.
Here we dissect the function of HuR in the cellular compartments
of the developing lung bud. We demonstrate that HuR controls
intercellular interactions that shape the lung as a branched structure.
Materials and methods
Mice
The generation of Elavl1ﬂ/ﬂ and epiblast-speciﬁc (Sox2Cre+Elavl1ﬂ/−;
referred to as Elavl1−/−) HuR mutants has been previously described
(Katsanou et al., 2009). Sftpc-Cremice (Okubo et al., 2005) were kindly
provided by B. L. Hogan (USA). Mice were backcrossed to C57Bl6/J and
were maintained in the animal facilities of the Biomedical Sciences
Research Center Alexander (Al.) Fleming under speciﬁc-pathogen free
conditions. Experiments on live animals were approved by the Hellenic
Ministry of Rural Development-(Directorate of Veterinary Services) and
by theAnimal Research and Ethics Committee of the BSRCAl. Fleming to
comply with FELASA regulations.
Histology
For general histology, embryos from timed-pregnant mice were
isolated at the times indicated and embryonic lungs were removed by
standard dissection protocols in phosphate-buffered saline (PBS).
Embryonic lungs were ﬁxed in neutral buffered formalin (BDH)
overnight at 4 °C. Fixation was followed by dehydration in an ethanol
series prior to embedding in parafﬁn and sectioning. Sections of 4–7 μm
were stained with hematoxylin and eosin for general histology
according to standard techniques or used for immunohistochemistry.
Alternatively, specimens were directly embedded onto OCT cryopre-
servative (TissueTec) and mounted via freezing for cryostat sections.
Lung bud and organ cultures
Isolation and culture of wild type and mutant distal lung buds were
performed as previously described (Bellusci et al., 1997). Brieﬂy, lung
primordia derived from E11.5 and E12.0 embryos were microdissected
with tungsten needles under sterile conditions to separate distal lung
bud tips – for use in FGF complementation assays – from the rest of lung
buds (amputated buds) that were used for FGF9 induced FGF10
expression and proliferation as shown in Supplementary Fig. 5.
Both distal lung buds and amputated lungs were cultured in Matrigel
diluted 1:1 with DMEM/F12. Lung bud cultures were treated with the
following recombinant FGFs (Peprotech EC): hFGF10 (250–500 ng/mL),
hFGF1 (200 ng/mL) and mFGF9 (200 ng/mL) for a period of up to 96 h;
media were replaced every 24 h. Amputated lung explants were used
for proliferation assays, immunohistochemistry or RNA analyses.
Cell culture
Primary mouse embryonic ﬁbroblasts (MEFs) were derived from
E13.5 embryos and were cultured in complete DMEM+10% FBS
(BiochromAG) for three to ﬁve passages prior to experimentation. For
stimulation, cultures were synchronized in DMEM media supple-
mented with 0.2% FBS and then treated with recombinant mFGF9
(200 ng/mL-Peprotech) for 6 h. Primary lungmesenchymal cells were
isolated from E13.5 fetal lungs as previously described (Lebeche et al.,
1999) and cultured in DMEM/F12 media supplemented with 0.5% FBS
in presence or absence of the abovementioned stimuli.Cellular proliferation and apoptosis
For cell death determination, terminal deoxynucleotidyltransfer-
ase-mediated dUTP-biotin nick end labeling (TUNEL) assays were
performed on parafﬁn-embedded sections using an in situ cell death
detection kit (cat. no. 11 684 795 910; Roche) according to
manufacturer's instructions. For proliferation assays, pulse BrdU
experiments were performed by the intraperitoneal injection of
pregnant females 3 h prior to sacriﬁce. Additionally, amputated lung
explants derived from E11.5 embryos were cultured as described
above in Matrigel diluted 1:1 with DMEM/F12. The explants were
treated with FGF9 (200 ng/ml) for 24 h before labeling for 3 h with
BrdU (10 μΜ in culture). For detection, cryostat sections (7 μm) were
permeabilized with proteinase K, treated with 2 N HCl and borate
buffer (pH 7.6), blocked and incubated with anti-BrdU antibody
(M0744; Dako-Cytomation). Peroxidase-conjugated anti-mouse IgG1
(Southern Biotech) or Alexa555 anti-mouse IgG secondary antibodies
(1:1000) were used. Sections were visualized either with DAB and
counterstained with haematoxylin or by ﬂuorescence microscopy.
Quantitation was performed in ×200 magniﬁcation images, either
using the ImageJ software (NIH; for BrdU) or manually (for TUNEL).
Immunoblotting, and immunohistochemistry
For western blots, total or nuclear lysates were analyzed on SDS-
PAGE according to standard protocols. Nuclear lysates were prepared
with NE-PER reagent (Pierce) according to the manufacturer's
instructions. For immunohistochemistry/immunoﬂuorescence cryo-
sections were used immediately, whereas parafﬁn sections were
deparafﬁnized and treated with microwaves in citrate buffer for
epitope unmasking. Primary antibodies included: HuR (3A2 or
19F12), actin (C11), Tbx4 (N-19) and FGF-10 (H121) for blots from
Santa Cruz; FGF-10 (ab9988) from Abcam for immunocytochemistry;
SMA from Sigma; and Ki67 (ab15580). Detection was performed
using horseradish peroxidase-conjugated, alkaline phosphatase-con-
jugated or Alexa-488/-555 (Southern Biotech) secondary antibodies.
Blots were visualized by enhanced chemiluminescence (ECL+;
Amersham). Sections were developed using either DAB or Fast Blue
Substrates (Sigma). Nuclear counterstaining was carried out with
haematoxylin, Nuclear Fast Red (Vector) or DAPI.
RNA analysis
Total RNA was derived from whole embryonic lungs or primary
MEFs using Trizol™ according to the manufacturer's protocol. For
cDNA synthesis, 2–5 μg of total RNAwas used for cDNA synthesis with
MMLV-RT (Promega). Quantitative-Real Time PCR (qRT-PCR) was
performed using EvaGreen SsoFast Qpcr mix (Biorad) on a RotorGene
6000 machine (Corbett Research). HuR-RNA immunoprecipitation
(IP) experiments, analysis of polysome-coupled RNA, and mRNA
stability assays were performed as previously described (Katsanou
et al., 2009). PCR primers are listed in Supplementary methods.
Results
HuR is required for distal lung branching
We previously used a Sox2-Cre mediated strategy to induce the
recombination of a loxP-ﬂanked Elavl1 allele (Elavl1ﬂ) in the epiblast
and bypass the placental defects that hamper the analysis of HuR
function beyond gastrulation (Katsanou et al., 2009). Examination of
the developing lungs in these HuR-null embryos revealed that the
formation of primary lung buds, the speciﬁcation of the trachea and
the initial branching of the stem bronchi occurred normally suggest-
ing that HuR is not required for the progression from the embryonic to
the pseudoglandular stage (E9.0–E12.0) of lung development (Fig. 1A;
Fig. 1. Impaired lung branching in fetal lungs lacking HuR. (A) Macroscopic comparisons of control (+/+) and mutant (−/−) lungs in the staged progression of lung development.
The left (le) and right cranial (cr), middle (me), caudal (ca) and accessory (ac) lobes are indicated. Numericals correspond to the numbers of epithelial branches observed in the left
lobes. (B) Comparative histology at embryonic days 13.5, 15.5 and 17.5. Stain: Haematoxylin/eosin. Note the expelled epithelial cells at E17.5 (inset) (C) Immunohistochemical
detection of HuR protein (blue) from the pseudoglandular to the saccular stage of lung development counterstained with Nuclear Fast Red (NFR). HuR-deﬁcient lungs at E14.5 are
used as negative controls. Size bars correspond to 100 μm.
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However, a block in the subsequent branching of most bronchi was
observed during the pseudoglandular stage (E12.0–E15.0). Starting at
E12.5, the mutant primitive lobes contained a lesser number of
epithelial branches than the control lobes. At E14.5, where control
lungs possessed an expanding network of distal branches, mutant
lungs contained dilated, sac-like structures and lost their lobular
architecture. These deformities persisted through the canalicular and
saccular stages of development i.e. till E17.5 (e.g. Fig. 1A). Histological
assessment revealed that a few rounds of branching to bronchioles
occurred in the mutant lungs, particularly in some of the developing
upper right lobes (Fig. 1B and Supplementary Fig. 3); however, distal
branches were absent and the dilated structures appearing from E13.5
in the mutant lungs were characterized by the absence of terminal
alveolar saccules and the presence of a few wide-bore bronchiolar
tubules connecting to large ﬂuid and debris-ﬁlled sacs (Fig. 1B). Thus,
the loss of HuR blocked the secondary branching of the major bronchi
to distal bronchioles and primitive alveoli that occurs between the
pseudoglandular and the canalicular stages of murine lung develop-
ment. A close examination of HuR protein during the progression of
these stages in wild-type lung buds revealed that its expression
changed during branching (Fig. 1C and Supplementary Fig. 2). At the
initiation of the pseudoglandular stage (E11–12.5), HuR was detected
in all epithelial and mesenchymal compartments, but its cellular and
subcellular distribution variegated. As branching progressed (i.e.
E15.5), HuR increased in distal epithelial cells and the surrounding
mesenchyme; toward the saccular stage (e.g. E17.5), HuR acquired a
widespread expression pattern that was maintained after birth. Taken
together, the expression of HuR in the developing lung reﬂected its
control over the morphogenesis of distal lung branches.
The loss of HuR from the developing endoderm does not block epithelial
differentiation or branching
The branching of the developing lung bud depends on the
proliferation of all compartments and the differentiation of endoder-
mal progenitor cells. To assess whether the loss of HuR affected these
responses, we administered BrdU and looked for changes in the
mutant lung buds. At E13.5, extensive proliferation was observed in
the epithelia and the mesenchyme of control buds. At the same age,
the mutant epithelia of proximal conducting airways contained
comparable numbers of proliferating cells; in contrast, the distal
developing epithelia and their mesenchymal support showed re-
ductions in the number of proliferating cells (Fig. 2A, C). At this age
TUNEL assays revealed also an increase in the number of apoptotic
cells in the epithelium and the mesenchyme of HuR-deﬁcient lungs
(Fig. 2B, D).
Immunohistochemical examination of E17.5 mutant lungs with
markers of differentiated epithelia (Supplementary Fig. 3) revealed
that regions maintaining a rudimentary architecture – particularly in
the upper right lobes – possessed cells expressing secretoglobin1α1
(Scgb1α1 or CC10) which marks Clara cells; and (b) epithelial cells
expressing the type I (squamous) and type II (cuboid) cells markers
Glycoprotein 38 (Gp38/T1α) and surfactant protein C (SPC), as well as
cells co-expressing CC10 and SPC which are considered bronchioal-
veolar progenitor/stem cells (BASCs) and normally reside in the
bronchioalveolar duct junctions (BADJ) (Kim et al., 2005;Nolen-
Walston et al., 2008;Reynolds et al., 2008). We noted that in the
mutant lungs, regions with incomplete branching maintained some
“BADJ” like structures that contained CC10+SPC+ cells; interestingly,
some of these double positive cells acquired both the typical
squamous phenotype of control BASCs as well as an “atypical”
columnar phenotype (Supplementary Fig. 4A). This phenomenon
could reﬂect a block in the transition to columnar, CC10+ epithelia
which were absent in distal parts of the mutant lungs, conﬁrming the
loss of distal airways. Furthermore, mutant epithelia were separatedby thin layers of disorganized mesenchyme expressing smooth
muscle actin (Sma; Supplementary Fig. 4B) beyond the layers
encircling the endoderm of proximal airways and the developing
blood vessels. Thus, endoderm differentiation can occur in the
absence of HuR but the lack in the formation of the distal structures
could relate to changes in mesenchymal organization.
To dissect further the function of HuR, we made use of the
conditional Elavl1ﬂ allele that was crossed to Sftpc-Cre transgenic mice
(Okubo et al., 2005), to delete HuR in the epithelial compartment of
the lung endoderm prior to E10.5. Sftpc-cre+Elavl1ﬂ/ﬂ embryos
developed to term and were breathing at birth. The recombination
of the Elavl1 locus was restricted to the lungs of the Sftpc-cre Elavl1ﬂ/ﬂ
embryos (Fig. 3A). Similarly, the deletion of HuR protein was conﬁned
to proximal and distal epithelial layers (Fig. 3 E–H). Examination of
lungs at E18.5 (Fig. 3 B–D) revealed the proper development of the
bronchial tree and the completion of all stages in lung development.
Thus, epithelial HuR is not required for lung branchingmorphogenesis
and does not affect the reciprocal communicationwith HuR-proﬁcient
mesenchyme. As a result, the branching defect of mutant buds relates
to the loss of mesenchymal HuR functions.The loss of HuR induces a deﬁciency in FGF10
In an effort to identify networks affected by the loss of HuR, we
isolated total RNA from control and mutant lungs at E11.5 to E12.5
and screened them for mRNAs involved in this process by quantitative
real-time PCR (qRT-PCR) (Fig. 4A). We detected mRNAs of pleiotropic
morphogens (e.g. retinoic acid receptor-RAR, and BMP4), or mRNAs
expressed in the mesenchyme (e.g. Fgf10, FgfR1c, Gli1, Tbx4, and
Wnt2a) or developing epithelia (Fgf9, FgfR2b, GATA6, Lef1, Shh, Sox2,
Spry1, Spry 2, and Ttf1). The most striking reductions (≤50%) were
observed in mRNAs encoding: FGF10, a major mesenchymal deter-
minant of primary lung bud formation and branching morphogenesis
(Cardoso and Lu, 2006;Maeda et al., 2007); TBX4, a T-box transcrip-
tion factor involved in endodermal branching and the transcriptional
regulation of the Fgf10 gene (Cardoso and Lu, 2006;Cebra-Thomas
et al., 2003; Sakiyama et al., 2003); and the epithelial receptor of
FGF10, FGFR2b, the growth inhibitor SPRY2 and the epithelial
transcription factor TTF1, all of which are induced by FGF10 in distal
epithelia (Cardoso, 2001;Cardoso and Lu, 2006;Maeda et al., 2007).
Signiﬁcant increases were detected in mRNAs encoding: FGF9, an
epithelia-derived inducer of mesenchymal/epithelial proliferation
and FGF10 expression (Colvin et al., 2001;del Moral et al., 2006);
BMP4 and WNT2a, induced by FGF9 and regulators of growth factor
signals; and SOX2 which is blocked by FGF10 to aid epithelial
progenitor differentiation during branching (Gontan et al., 2008).
Given that besides the Fgf10 and Tbx4 mRNAs, other mesenchymal
mRNAs (FgfR1c, Gli1 and Wnt2a) showed minimal or positive changes
in their expression, we hypothesized that HuR-deﬁcient buds may not
lack a properly expanding mesenchyme but rather lack sufﬁcient
FGF10 or cell autonomous Tbx4 transcription which are needed for
branching. Indeed, the levels of FGF10 and Tbx4 proteins were
consistently less than 50% in mutant lung extracts at E12.5 (Fig. 4B).
By exploiting an antibody applicable for the detection of FGF10
protein in tissues, we further detected diffused mesenchymal and
parabroncial FGF10 signals (Mailleux et al., 2005), in control sections
that were almost undetectable in mutant sections (Fig. 4C). Most
importantly, the reduction of Tbx4 and Fgf10mRNAs – but not of other
mesenchymal mRNAs like Gli1 or Bmp4mRNAs –was also apparent in
cultured lung mesenchymal cells (LMCs) isolated from mutant E13.5
lungs and passaged for – at least – two generations (Fig. 4D); this
suggested that the observed decreases of these mRNAs in the
developing buds were not due to changes in mesenchymal cellularity
but rather in their expression. Thus, the lung branching defect of HuR-
deﬁcient embryos correlates with a deﬁciency in Tbx4 and FGF10.
Fig. 2. Abnormal proliferation and apoptosis of fetal lungs lacking HuR. (A) Immunohistochemical detection of BrdU incorporation (brown) in sections from control (+/+) and
mutant (−/−) lungs at E13.5, at a ×100 and ×200 magniﬁcation.m:mesenchyme; p: proximal epithelium; d: distal epithelium. H,Hematoxylin counterstain. (B) TUNEL detection of
apoptotic cells (TdT; blue) in control and mutant lungs at E13.5, at ×100 and ×200 magniﬁcation. NFR, Nuclear Fast Red counterstain. (C) Bar graphs and corresponding p values
derived from the comparison of the percentages of BrdU+ve cells (±SEM) in control and mutant lungs at E13.5. Data derived from high power ﬁeld measurements of 2703±244
mesenchymal cells and 553±46 epithelial cells per lung and from 3 control lungs; and 1835±283 mesenchymal cells and 442±37 epithelial cells per lung from 4 mutant lungs.
(D) Bar graphs and corresponding p values derived from the comparison of the number of TUNEL positive cells per high power ﬁeld (±SEM) in the epithelium and mesenchyme of
control (n=3) and mutant (n=3) lungs. H: haematoxylin.
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To verify that mutant lungs suffered from a loss in FGF10 signals,
we dissected distal lung buds (endoderm plus mesenchyme) from
E11.5 embryos and cultured them in Matrigel supports (Supplemen-
tary Fig. 5). As shown in Fig. 5A, control buds divided internally after
48 h in culture suggesting that the limited mesenchyme or FGF
present in the bud forced the adjacent endoderm to slowly branch. In
striking contrast, a limited division was observed in the mutant buds
and they failed to form deﬁned branches under the same culture
conditions. FGF1, which can bind to FGFR2 (Bellusci et al., 1997), could
induce endodermal budding in the mutant cultures suggesting that
the mutation affected the presence of FGF10 and not FGFR2 signaling.
On the other hand, the addition of FGF10 rescued the branching defect
of HuR-null buds and induced endodermal swelling and rapid
budding, as in control buds, which could be observed even at 48 hin culture. Thus, FGF10 is crucial to overcome the branching
impairment in HuR-null lung buds (Fig. 5B).
To discriminate between HuR-related defects in the proliferation
of the mesenchyme from an effect of HuR on FGF10 biosynthesis, we
analyzed the response of HuR-null lung buds to FGF9. FGF9 is an
essential epithelia-derived regulator of lung mesenchyme and
deﬁcient animals possess hypoplastic and poorly branched lungs
that show reduced mesenchyme and Fgf10 mRNA expression (Colvin
et al., 2001). Subsequent studies demonstrated that FGF9 derived
from the mesothelium and the distal epithelium can induce at least
three processes supporting bud extension in an independent fashion :
(a) the expansion of the adjacent mesenchyme and the repression of
its differentiation to smooth muscle cells; (b) the induction of
mesenchymal FGF10, to act on the developing epithelium, and
(c) the partial – yet direct – induction of epithelial proliferation
through binding to epithelial FGFR2b (del Moral et al., 2006;White
Fig. 3. The loss of epithelial HuR does not impair lung development. (A) PCR-based
detection of targeted (ﬂ) and Cre-recombinant (null) loci in DNA extracts from tissues
of Sftpc-cre+Elavl1ﬂ/ﬂ E18.5 embryos. Extracts from Elavl1ﬂ/ﬂ lungs are shown as
controls. (B–D)Macroscopic and histological analysis of Sftpc-cre+Elavl1ﬂ/ﬂ and Elavl1ﬂ/ﬂ
lungs at E18.5. Low (E, F) and high power (G, H) immunohistochemical detection of
HuR (brown) in sections from E18.5 Elavl1ﬂ/ﬂ and Sftpc-cre+Elavl1ﬂ/ﬂ lungs indicating
the epithelial deletion in the latter. Scale bar: 100 μm.
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induce the proper dilatation of the epithelium in control buds; a lesser
yet detectable response was also observed in mutant buds suggestingthat FGF9 could also partially overcome the branching defect induced
by the loss of HuR. To understand the target of FGF9 functions on the
mutant buds, we compared its effects on amputated lung explants
that possess a lower level of FGF10 than the distal tips (Bellusci et al.,
1997) and thus changes in FGF10 expression versus proliferation
could be more readily observed. Analysis of BrdU incorporation using
these FGF9-treated explants, showed a clear increase in the epithelial
and mesenchymal proliferation in both the control and the mutant
explants (Fig. 6A, B). Given that FGF9 can also repress the
differentiation of the lung mesenchyme to smooth muscle to enforce
a proliferative state (del Moral et al., 2006), we also examined the
response of LMCs to this factor. As demonstrated by the Ki67 and SMA
signals, FGF9 could induce the proliferation and the reduction in SMA
expression in HuR-null LMCs as in control LMCs (Fig. 6D). In contrast,
and although FGF10 protein was locally enhanced in FGF9-treated
control explants, the mutant explants lacked FGF10 protein expres-
sion (Fig. 6A). qRT-PCR analyses of explant-derived RNA (Fig. 6C)
veriﬁed that FGF9 could induce a two-fold increase in Fgf10mRNA in
HuR-proﬁcient explants, whereas the basal levels of this mRNA were
reduced in HuR-deﬁcient explants and not altered by the presence of
FGF9. We also observed a dramatic increase in Tbx4 mRNA in FGF9
treated HuR-proﬁcient explants which was in compliance to previous
observations suggesting a relationship between the domains of
expression Fgf10 and Tbx4 mRNAs in embryonic lung mesenchyme
(delMoral et al., 2006); in contrast and although the Tbx4mRNA could
be induced in HuR-deﬁcient explants, both its basal and inducible
levels were signiﬁcantly reduced relative to control values. The
augmented responses of Fgf10 and Tbx4mRNAs in FGF9-treated, HuR-
proﬁcient explants also correlated to an increase in the levels of
Elavl1/HuR mRNA (Fig. 6C). Collectively, our data demonstrate that
HuR is not required for the transmission of FGF9 signals promoting the
proliferation of mesenchymal and epithelial cells but is required for
the inducible biosynthesis of FGF10 in the lung mesenchyme.
HuR controls the synthesis and translation of Fgf10 mRNA in
mesenchymal cells
Aprevious high-throughput screen inmouse embryonicﬁbroblasts
(MEFs) had identiﬁed the Fgf10 and the Tbx4mRNAs as potential HuR
targets (Katsanou et al., 2009). In the same study, HuR-null MEFs
showed a reduction in the basal accumulation and transcription of the
Fgf10 gene that correlated with a reduction in the basal accumulation
and stability of Tbx4mRNA; conversely, the overexpression of HuR in
these MEFs could increase Tbx4 mRNA stability and Fgf10 mRNA
abundance. However, the study failed to identify any evidence for the
post-transcriptional regulation of Fgf10 mRNA. Our current ﬁndings
suggested that HuR functions could extent to the inducible regulation
of the Tbx4 and Fgf10mRNAs.We therefore examined their expression
in cultured LMCs, in the absence or presence of induction by FGF9 (del
Moral et al., 2006;Jean et al., 2008;White et al., 2006). The Fgf10 and
Tbx4mRNAswere readily detectable in resting HuR+ LMCs;moreover,
the stimulation of these cells with FGF9 led to 1.8 fold and 2-fold
increases in Fgf10 and Tbx4mRNAs respectively (Fig. 7A). In the same
cells, FGF9 induced a substantial increase in Elavl1/HuR mRNA
conﬁrming that FGF9 targets HuR's biosynthesis. In contrast, the
basal levels of Fgf10 and Tbx4 mRNAs were signiﬁcantly reduced in
HuR− LMCs. Moreover, the addition of FGF9 had no effect on the levels
of these mRNAs in HuR− LMCs, suggesting that HuR is required for
their basal and inducible regulation.
The next series of experiments necessitated a large number of cells
(N108 per condition and per assay) and thus the reduced number of
primary LMCs derived from E13.5 embryos could not meet this
requirement. Thus, we switched to MEFs which allowed more detailed
analyses due to their easy maintenance and expansion in culture. The
basal and inducible accumulation of Fgf10, Tbx4 and Elavl1/HuRmRNAs
in HuR+ and HuR−MEFswas similar to that in the corresponding LMCs
Fig. 4. Reduced FGF10 in fetal lungs lacking HuR. (A) Bar graph depicting the differential (fold change) levels of morphogenic mRNAs in extracts from fetal lungs at the early
pseudoglandular stage. Data (arbitrary units±SEM) derived from qRT-PCR experiments performed in RNAs from N5 lungs per genotype. The dotted line represents the control value
of 1. * and ** denote minimal and maximal statistical differences with pb0.01, respectively. (B) Detection of FGF10 and Tbx4 proteins in immunoblots from control and mutant lung
extracts at E12.5. (C) Immunohistochemical detection of FGF10 (green) in control and mutant sections from E12.5 lungs displaying reduced FGF10 detection in mesenchyme
adjacent to developing epithelial tips of mutant lungs. (D) qRT-PCR analysis in isolated lung mesenchymal cells showing reduced levels of Fgf10 and Tbx4mRNAs but not for Gli1 nor
Bmp4 mRNAs in HuR-deﬁcient cells. Scale bar: 100 μm.
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increased in total protein extracts from FGF9-treated HuR+ MEFs,
whereas it was reduced in resting and stimulated HuR−MEFs (Fig. 7B).
The Tbx4 protein was clearly detectable in nuclear extracts from HuR+
MEFs; interestingly FGF9 induced an increase in Tbx4 protein levels as
well as a shift in size (Fig. 7C), suggesting that FGF9 affects both the
expression and the post-translational modiﬁcation of Tbx4. In HuR−
MEFs, FGF9could still causea change in the sizeof Tbx4protein, but both
its basal and inducible levels were dramatically reduced relative to its
levels in HuR+ MEFs. Finally, the examination of HuR protein in HuR+
MEFs revealed that FGF9 induced an increase in the levels ofHuRprotein
but not in its nucleo-cytoplasmic distribution (Fig. 7B and Supplemen-
tary Fig. 7).
Next, we used HuR:RNA immunoprecipitation assays (R-IPs) from
HuR+ MEFs to detect whether HuR's associations to the Fgf10 andTbx4 mRNAs varied following stimulation. The speciﬁcity of associa-
tions was controlled by (a) HuR IP assays fromHuR−MEF extracts and
(b) isotype mIgG1 IP assays from HuR+ MEF extracts (Fig. 7D),
whereas the quality of the IP reactions was monitored via immuno-
blotting (Fig. 7E). In each IP, the presence of eachmRNAwas tested by
qRT-PCR and positive associations were considered if mRNAs were
enriched, compared to control IPs. Given the ﬂuctuations in HuR
levels, values were normalized to levels of GAPDHmRNA, an abundant
mRNA that is not a speciﬁc target of HuR but is present as a low-level
contaminant in all HuR-IP samples and relates to the quantity of
protein in the IP material. As shown in Fig. 7D, the Fgf10 mRNA
associated with HuR under all conditions tested and to a similar
extend. In contrast, the Tbx4mRNA associatedwith HuR in the absence
of stimulation, but this association increased 2-fold in the presence of
FGF9-stimulation.
Fig. 5. Effect of recombinant FGFs on the branching of HuR-deﬁcient distal buds. (A) Isolated E11.5 distal lung bud tips cultured in aMatrigel support without FGFs. Limited branching
of the endoderm surrounded bymesoderm is observed in the control (+/+) but not in themutant (−/−) lung bud tips after 48 h. Shown are representative images from 11 explants
derived from 6 to 7 lungs per genotype (B) Effect of recombinant FGF10 on E11.5 lung buds. Note that both genotypes exhibit extending budding between 48 and 96 h. Shown are
representative images from 8 explants derived from 4 lungs per genotype (C) Response of lung buds to the presence of recombinant FGF1. Shown are representative images from 4
explants derived from 2 lungs per genotype. (D) Response of lung buds to the presence of recombinant FGF9. Shown are representative images from 8 explants derived from 5 lungs
per genotype. In some micrographs, the endodermal (e) and mesenchymal (m) layers are indicated.
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analyzed their post-transcriptional regulation in HuR+ and HuR−
MEFs. To assess whether the loss of HuR affected the basal and/or the
inducible stabilization of the Tbx4 and Fgf10mRNAs, we blocked their
transcription in MEFs using actinomycin D and measured their
temporal disappearance (decay) via qRT-PCR. The remnant levels of
Tbx4 and Fgf10 mRNAs were then used for the estimation of the
corresponding mRNA half lives in the absence or presence of FGF9
(Fig. 7F and Supplementary Fig. 8). The Fgf10 mRNA appeared asrelatively unstable in HuR+ MEF and its half life increased in the
presence of FGF9; interestingly the half lives of the Fgf10 mRNA in
untreated and FGF9-treated HuR− MEF were comparable to control
values. Thus, HuR is not required for the stabilization of the Fgf10
mRNA and the observed changes in its abundance in HuR− MEFs are
probably due to effects on Fgf10 mRNA transcription or maturation.
The half-life of the Tbx4 mRNA was also signiﬁcantly augmented by
FGF9 treatment in HuR+ MEFs. In sharp contrast however, the decay
of Tbx4 mRNA in HuR− MEFs was persistently reduced under basal
Fig. 6. Effect of FGF9 on HuR-deﬁcient amputated lungs. (A) Isolated E11.5–E12.0 amputated lung explants cultured in Matrigel in presence or absence of recombinant FGF9 for 6 h.
Shown are photomicrographs and immunoﬂuorescent stains for BrdU, HuR and FGF10 and counterstained by DAPI. FGF9 can induce proliferation of mesenchyme (m) and
epithelium (e) both in control and mutant specimens as shown by the detection of BrdU positive cells on sectioned tissue. On the other hand, a lack of FGF10 is detected in the
mesenchyme adjacent to developing epithelial tips of mutant lungs, which becomes locally enhanced in FGF9 treated control lungs. (B) Bar graphs depicting the percentage of BrdU
incorporation per high power ﬁeld, in the epithelium and the mesenchyme of control and mutant lung explants. Data derived from high power ﬁeld measurements of 1716±103
mesenchymal cells and 220±33 epithelial cells from 4 control explants; and 1335±83mesenchymal cells and 257±27 epithelial cells from 4mutant explants. (*) denote statistical
differences to untreated explants with pb0.05. (C) qRT-PCR detection of Fgf10, Tbx4 and Elavl1/HuR mRNAs in extracts from control and mutant lung explants treated with FGF9
(200 ng/ml) for 6 h. HuR mRNAmeasurements in the mutants were omitted since they were below detection. Values (±SEM) presented as fold changes to the values of untreated
control explants. Vertical p-values denote statistical differences to unstimulated control explants; horizontal p-values denote differences between stimulated control and mutant
explants or between untreated and treated mutant explants. (D) Immunoﬂuorescent detection of SMA (red) and HuR (green) on control (+/+) and HuR deﬁcient (−/−) cultured
LMCs, in the absence or presence of FGF9 for 48 h. (E) Bar graph showing the percentage of proliferating-Ki67 positive-LMCs in response to FGF9. Data collected from
immunoﬂuorescent stainings of cells with anti-Ki67 (see also Supplementary Fig. 6). *pb0.05 relative to the unstimulated conditions.
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276 N. Sgantzis et al. / Developmental Biology 354 (2011) 267–279conditions and was not altered by the addition of FGF9. Thus, changes
in the abundance of Tbx4mRNA in HuR- cells correlate to its defective
stabilization.
To assess whether HuR could affect the translation of its target
mRNAs, we fractionated monosomes (i.e. containing non-translated
mRNAs) and polysomes (i.e. containing mRNAs engaged in transla-tion) from the cytoplasm of MEFs using sucrose gradients (Supple-
mentary Fig. 9); extracted RNAs were subsequently analyzed via qRT-
PCR for the detection mRNAs in each fraction (Fig. 7G and
Supplementary Fig. 9). The monosomal/polysomal fractions and the
distribution of the GAPDH mRNA in these fractions from control and
mutant MEFs were comparable under all tested conditions, indicating
277N. Sgantzis et al. / Developmental Biology 354 (2011) 267–279that the mutation did not affect the translational machinery. The
polysomal distribution of the Tbx4 mRNA in HuR+ MEF was
augmented by FGF9, but this response was also invariably observed
in HuR−MEF; thus, HuR is not required for the translational control of
this mRNA. In sharp contrast, and although the polysomal distribution
of the Fgf10mRNAwas comparable between control andmutantMEFs
under basal conditions, a detectable increase in polysomal Fgf10
mRNA that was induced by FGF9 in HuR+ MEF was not observed in
HuR-MEF; thus HuR is required for the inducible translation of the
Fgf10 mRNA.
Taken together, our data demonstrate that HuR: (a) responds to
signals targeting the lungmesenchyme at the levels of its biosynthesis
and binding to its targets; (b) regulates Fgf10mRNA both directly – at
the level of its inducible translation – and indirectly at the level of its
abundance; (b) regulates the Tbx4 mRNA at the level of its inducible
stabilization. All these effects correlate with the critical role of HuR in
lung branching morphogenesis.
Discussion
In this study we unraveled the role of post-transcriptional
regulation by HuR in lung development. Our data demonstrate that
HuR is a determinant of tissue remodeling interactions that govern
branching morphogenesis. Although the embryonic ablation of HuR
did not block the generation of primary branches, the majority of
these branches failed to divide further and to form bronchioli and
primitive alveoli. Several epithelial mutations are known to block lung
branching morphogenesis, including mutations in molecules whose
mRNAs are targeted by HuR-like members of the Wnt/β-catenin
pathway (Briata et al., 2003;Katsanou et al., 2009;Leandersson et al.,
2006). HuR has also been considered as a positive regulator of
epithelial proliferation, differentiation and survival (Ghosh et al.,
2009). However, the presence of differentiating epithelia in HuR-
deﬁcient lungs and their proper branching in mutants lacking
epithelial HuR demonstrate that HuR is neither required for intrinsic
programs guiding endodermal responses, nor for the expression of
derived autocrine/paracrine signalers. Similarly, we have reported
previously that the lack of HuR from developing endothelia does not
hinder any aspects of embryonic development, including vascular
morphogenesis of the lung (Katsanou et al., 2009 and data not
shown). Thus, and by exclusion, we suggest herein that the arrested
secondary branching of the HuR− endoderm stems from a defect on
the surrounding mesenchyme. In the current study, we have not used
transgenic systems to restrict the deletion of HuR in the developing
lungmesenchyme, and thus we cannot exclude any additional defects
than the ones reported herein; still the data derived from the
examination of explant cultures, LMCs and MEFs support our
hypothesis that a dominant mesenchymal defect in HuR-deﬁcient
lungs stems by the loss of HuR's control over the biosynthesis of Tbx4
and FGF10.
The key role of FGF10 in lung branching outgrowth and the effects
of its binding to FGFR2 in the nearby epithelium are well documented.
Fgf10mRNA is present in discreetly localized sites in the mesenchyme
from the earliest stages of lung formation and subsequently un-Fig. 7. HuR regulates the Tbx4 and FGF10 atmultiple levels. (A) Bar graphs depicting the differen
HuR− LMCs and MEFs in the presence or absence (UNT) of FGF9. Data (arbitrary units±SEM
genotype. (*) and p=values denote differences from untreated controls. (B) Detection of FGF1
basal or FGF9-treated conditions. GAPDH is shown as a loading control. (C) Detection of Tbx4 p
FGF9-treatedconditions.U1 snRNP is shownasa loading control. (D)qRT-PCRdetectionof Fgf10
treated FGF9. Data (biological triplicates±SEM) are represented as fold enrichment of themRN
MEF (Vs Ko). Enrichment levels were normalized to the levels of Gapdh mRNA. (*) p=v
(E) Representative anti-HuR immunoblot of the anti-HuR IP ormIgG1 IPmaterial derived from
blot. The signals for HuR and IgG heavy chains are indicated. (F) Evaluation of Fgf10 and Tbx4m
from decay plots from three independent experiments. (*) denote statistical differences betw
control andmutant values. (G) qRT-PCR detection of Fgf10mRNA inmonosomal/polysomal frac
individual fractions and presented as total monosomal or polysomal percentages (±SD) of cytdergoes a dynamic shift to sites of prospective bud or branch
formation (Bellusci et al., 1997). As previously described and also
demonstrated here, exogenous FGF10 can induce the expansion and
budding of distal epithelial tips (Bellusci et al., 1997), and denuded
epithelia proliferate and migrate toward localized sources of FGF10
(Weaver et al., 2000). Themost convincing evidence for the key role of
FGF10 is found in the block of epithelial branching by mesenchymal
deletion of FGF10 or epithelial deletion of FGFR2 in the mouse (Abler
et al., 2009). HuR deﬁcient lungs phenocopy the FGF10-deﬁcient state
or states of FGF10 suppression that occur due to the epithelial
overexpression of Sox2 and Bmp4 (Bellusci et al., 1996;Gontan et al.,
2008). This conclusion is clearly supported by the rescue of HuR-
deﬁcient distal buds by the exogenous provision of FGF10. Our data
also supports a positive relationship between Tbx4 and FGF10. Ectopic
expression of Tbx4 induces lung bud outgrowth (Sakiyama et al.,
2003) and activates FGF10 expression whereas blocking Tbx4
functions attenuates FGF10 synthesis and branching (Cebra-Thomas
et al., 2003). Similarly, the positive effect of FGF9 on mesenchymal
FGF10 expression has also been hypothesized to depend – at least in
part – upon Tbx4 transcription (del Moral et al., 2006). As
demonstrated herein, HuR appears to be in the epicenter of the
Tbx4:FGF10 axis since it can target both of their corresponding
mRNAs.
Is HuR required solely for the regulation of mesenchymal Tbx4 and
FGF10?HuR could also be required for the proliferation and survival of
mesenchymal cells, especially since the mutant mesenchyme showed
symptoms of early degeneration. However several pieces of evidence
argue against a cellular defect in mesenchymal responses as the cause
of defective lung branching in HuR-deﬁcient buds. Firstly, the foregut
outgrowth and the initial branching of mutant lung buds occur
normally. Secondly, HuR-deﬁcient mesenchyme can respond to
expand ex vivo in the presence of growth stimulating signals such
as FGF9. Similarly, we did not observe any symptoms of defective
proliferation of cell death in HuR− LMCs which also responded to
FGF9 signals. Considering our expression data, the apoptotic damage
in the lung mesenchyme could be a secondary effect due to the loss of
mesenchymal:epithelial FGF cross talk and the expression of epithelial
regulators counteracted by FGF10 signals such as Shh, Sox2 or Bmp4
(Bellusci et al., 1997;Cardoso and Lu, 2006;Gontan et al., 2008). This is
also supported by the excessive number of cells acquiring a smooth
muscle phenotype in the mutant lungs, a phenotype which is known
to be enforced by excessive Bmp4 signaling (Jeffery et al., 2005). Thus,
it is most likely that FGF10 deprivation is a key cause for the defective
branching of HuR-deﬁcient buds.
While we demonstrate a relationship between HuR and FGF10
expression, we cannot provide an answer to why other FGF10
dependant processes – like the primary outgrowth of the lung buds,
the branching of the stem bronchi and some secondary branching in
the upper lobes – do occur in HuR-deﬁcient lungs. A possible
explanation could be that lower FGF10 levels, or lower signal
thresholds, are required for these primary events than the ones
needed for secondary branching. This could also relate to the small
size or the proximity of primary and septated lobes to the trachea and
the requirement a more limited diffusion of FGFs as opposed to thetial (fold change) response of Fgf10, Tbx4 and Elavl1/HuRmRNA in extracts fromHuR+ and
) derived from qRT-PCR experiments performed in RNAs from at least three cultures per
0 and HuR proteins via immunoblots of total lysates from control and mutant MEFs under
rotein via immunoblots of nuclear extracts from control and mutant MEFs under basal or
and Tbx4mRNAs immunoprecipitatingwithHuR inHuR+MEFextracts untreated (UNT)or
A inHuR IP samples compared to its abundance in IgG1 IPs (Vs IgG) or HuR IPs fromHuR−
alues indicate statistical differences between stimulated and unstimulated conditions.
HuR-proﬁcient and deﬁcient MEFs after treatment with FGF9. All lanes are from the same
RNA stability in actinomycin D-treatedMEFs. Data are half-lives inminutes (±SD) derived
een treated and untreated conditions whereas (**) denote statistical differences between
tions from untreated (UNT) or FGF9 treatedMEFs. Data are derived frommeasurements in
oplasmic mRNA. *p values denote statistical differences in polysomal fractions.
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could be that different spatial/feedback mechanisms – and hence HuR
requirements – are needed to conﬁne FGF10 expression domains to
proximal than distal branches. Finally, we cannot exclude a partial
replacement of FGF10 functions by other FGFs that could be affected
positively by the loss of HuR and remain to be identiﬁed.
Ona cellular level, ourdata clearly demonstrate thatHuR responds to
signals regulating mesenchymal:epithelial interactions – like FGF9 – to
control the biosynthesis of Tbx4 and FGF10 inmesenchymal cells, albeit
at different levels asproposed in ourmodel in Fig. 8. In the current study,
we have not examined whether the domains of HuRmRNA expression
overlap with the expression domains of the Tbx4 and Fgf10 mRNAs
during distal branching in vivo; still our studies on MEFs, MLCs and
explants show that the biosynthesis of HuR responds to branching
signals and correlates closely to the responses of its target mRNAs.
Our analyses demonstrated that HuR affects the accumulation of
the Fgf10 mRNA indirectly, since the turnover of this mRNA was not
affected in HuR− MEFs. Based on our previous observation on the
reduced basal transcription of the Fgf10 gene in these cells (Katsanou
et al., 2009), we hypothesize that HuR controls the biosynthesis of
transcription factors targeting the Fgf10 gene. Although not directly
addressed, we speculate that Tbx4 is one such transcription factor.
Tbx4 and Tbx5 share expression domains with Fgf10 and can
synergize with the zinc-ﬁnger transcription factor Sall4 toward the
activation of the Fgf10 promoter in mesoderm-derived cells (Koshiba-
Takeuchi et al., 2006). We have previously shown that the loss of HuR
did not affect the basal transcription of the Tbx4 gene whereas the re-
introduction of HuR increased Tbx4 mRNA accumulation in a fashion
similar to the accumulation of the Fgf10 mRNA. Although the loss of
HuR may have also affected the inducible transcription of the Tbx4
gene, the fact that HuR associates directly with the Tbx4 mRNA and
that its loss increases its degradation are in support for a direct role of
HuR toward the Tbx4 mRNA stabilization.
We also revealed that HuR can affect the inducible protein-synthesis
of FGF10 by affecting Fgf10mRNA translation. Our data shows that FGF9
increases the translation of the Fgf10 mRNA to FGF10 protein in
mesenchymal cells and that this effect does not occur in the absence of
HuR. However, the fact that HuR binding to the Fgf10 mRNA –
presumably via its 3′ AU-rich element (Katsanou et al., 2009) –
remained unaltered in the presence of FGF9 is puzzling. One possibility
could be that HuR cooperates or antagonizes other inducible co-factors
to regulate the inducible translation of the Fgf10 mRNA. For example,Fig. 8. Proposed model for the regulation of Tbx4 and FGF10 biosynthesis in
mesenchymal cells during lung branching. Positive inducers derived from developing
epithelia, such as FGF9, regulate HuR levels and its associations with the Tbx4 and Fgf10
mRNAs. Through these associations HuR regulates the Tbx4 protein by the inducible
stabilization/destabilization of the Tbx4mRNA to act on its target promoters which may
include the Fgf10 promoter. This or additional transcription factors that require HuR for
their expression (TFX) can facilitate the inducible transcription of the Fgf10 gene. At the
same time the association of HuRwith the Fgf10mRNA controls the translational output
of FGF10 protein which feeds back to act on the developing epithelium.this effect could involve the interaction of HuR with micro RNAs
(miRNAs) (Bhattacharyya and Filipowicz, 2007;Kim et al., 2009) that
control translational regulation. As suggested by the analysis of Dicer-
deﬁcient mutants, mi- or si- RNAs plays a role in the regulation of Fgf10
mRNA translation during lung branching (Harris et al., 2006), and
considering our ﬁndings, it seems likely that biosynthesis of FGF10 is
controlled by a combination of HuR and miRNAs. In addition, and as
indicated for the Fgf10 mRNA, HuR may affect multiple stages in the
biosynthesis of its target mRNAs in the lungmesenchyme in an indirect
fashion and in response to numerous signals that remain to be
indentiﬁed. Future studies will reveal the actual domains required for
the post-transcriptional regulation of the Tbx4 and Fgf10 mRNAs, the
effect of HuR on associated transcription and maturation factors, its
response to positive as well as negative regulators of branching and the
involvement of small RNA populations in these processes.
In conclusion, the identiﬁcation of HuR as a determinant of lung
branching supports the central role of post-transcriptional control in
morphogenetic programs. Most importantly, the requirement of HuR
for lung branching highlight its role as an organizer of mesenchyme-
driven epithelial remodeling and implicates it in tissue regeneration.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.04.003.
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